EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA

Abstract New therapeutic approaches are needed to improve the prognosis of Glioblastoma (GBM) patients. With the objective of identifying alternative oncogenic mechanisms to abnormally activated EGFR signaling, one of the most common oncogenic mechanisms in GBM, we performed a comparative analysis o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2023-11, Vol.25 (Supplement_5), p.v237-v237
Hauptverfasser:	Verreault, Maite, Vilchis, Irma Segoviano, Rosenberg, Shai, Lemaire, Nolwenn, Schmitt, Charlotte, Guehennec, Jeremy, Royer-Perron, Louis, Thomas, Jean-Leon, Lam, Tukiet T, Dingli, Florent, Loew, Damarys, Ducray, Francois, Paris, Sophie, Carpentier, Catherine, Marie, Yannick, Laigle-Donadey, Florence, Rousseau, Audrey, Pigat, Natascha, Boutillon, Florence, Bielle, Franck, Mokhtari, Karima, Frank, Stuart J, de Reynies, Aurelien, Hoang-Xuan, Khe, Sanson, Marc, Goffin, Vincent, Idbaih, Ahmed
Format:	Artikel
Sprache:	eng
Schlagworte:	Preclinical Experimental Therapeutics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!